PhoenixBio Co., Ltd. (TYO:6190)

PhoenixBio Revenue

PhoenixBio had revenue of 258.00M JPY in the quarter ending June 30, 2026, a decrease of -35.50%. This brings the company's total for the last twelve months to 1.42B, down -4.62% year-over-year. In the fiscal year ending March 31, 2026, PhoenixBio had annual revenue of 1.57B with 1.56% growth. That makes PhoenixBio the 37,793rd largest company in the world by revenue and 3,736th in Japan.

• Revenue (ttm): 1.42B
• Revenue Growth: -4.62%
• P/S Ratio: 0.89
• Revenue / Employee: 25.87M
• Employees: 55
• Market Cap: 1.27B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States of America 853.06M 54.5%
• Japan 423.63M 27.1%
• Europe 193.88M 12.4%
• Others 94.97M 6.1%

Fiscal year ended Mar 31, 2026 See the full PhoenixBio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.57B	24.00M	1.56%
Mar 31, 2025	1.54B	-174.00M	-10.15%
Mar 31, 2024	1.72B	-409.00M	-19.26%
Mar 31, 2023	2.12B	800.00M	60.42%
Mar 31, 2022	1.32B	311.00M	30.70%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error